Aims: We have investigated the short term effects of fluorescein angiography on the blue±yel-low, red±green, and luminance contrast senstivity of patients with early age-related macular degeneration (ARMD).
Introduction
Fluorescein angiography is routinely used in the ophthalmologic examination of age-related macular degeneration (ARMD), providing essential information on retinal and choroidal vasculature. The procedure involves injection with a¯uorescent dye (sodium¯uor-escein) followed by photography using repeated, intense bursts of short-wavelength light. Except for rare anaphylactic reactions, it is generally considered safe and without lasting side eects. Furthermore, an earlier study has shown no measurable de®cits in visual acuity, luminance or colour sensitivity 48 h after angiography (Friedman et al., 1994) . However, key visual de®cits that are only apparent in the short term have not been investigated.
The potential risk of visual damage from¯uorescein angiography in patients with ARMD does however exist (see Ham et al., 1980; Bloome, 1980) . Firstly, the levels of light exposure lie within half a log-unit of the limit for safe exposure established by the American National Standard Institute (ANSI). As this standard is based on the exposure limit for ophthalmoscopically observable damage, functional visual de®cits may occur at signi®cantly lower exposure levels than those established by the ANSI (Mainster et al., 1983) . Furthermore, the ANSI standard is based on measurements using continuous light exposure, and there is evidence that greater damage results from exposure to repeated light bursts such as those used in¯uorescein angiography (Sperling et al., 1980) . A third important consideration is that the occurrence of ARMD, an ailment purportedly linked to long-term light damage (Young, 1994; Taylor et al., 1990; Bressler et al., 1989) , may increase susceptibility to further light damage. Evidence for this appeared in one study showing signi®cantly longer visual recovery times for ARMD patients (8 min) than in normal patients (less than 1 min) following¯uorescein angiography exposure (Collins and Brown, 1989) . Finally, studies in rabbits have shown directly that the presence of intravenous sodium¯uorescein increases susceptibility to retinal light damage. In our study, we investigated the short-term eects of¯uorescein angiography on visual performance on ARMD patients. In order to study these eects, we use a non-invasive technique for measuring small visual de®cits following a routine¯uorescein angiography test. We performed precise measurements of visual contrast sensitivity in these patients immediately before and after¯uorescein angiography. Comparison between these two measurements (before and after) for each patient was the best means of establishing a reliable control condition, given the wide inter-patient variability observed in these measurements. The three colour cardinal stimuli (red±green, blue±yellow, luminance) were selected. Selective blue±yellow sensitivity de®cits have been previously observed in ARMD patients under normal testing (Haegerstrom-Portnoy & Brown, 1989) and in primates following exposure to short-wavelength visible and ultraviolet light (Sperling et al., 1980) . It is therefore conceivable that exposure to such light in¯uorescein angiography may preferentially aect the already susceptible blue±yellow neural mechanism in ARMD patients. Our results on our nine ARMD patients showed no measurable losses in red±green and luminance contrast sensitivity followinḡ uorescein angiography, but a small, yet statistically signi®cant, blue±yellow contrast sensitivity de®cit. We conclude that colour-speci®c measurements of contrast sensitivity provide a viable means of investigating light damage that cannot be ophthmoscopically observed.
Methods

Patients
We measured contrast sensitivity in the less aected eye of nine early ARMD patients (Table 1) scheduled to undergo¯uorescein angiography at our clinic. Visual acuity was 20/60 or better in all tested eyes, and there were no exudative complications. The experiments were conducted in accordance with the Declaration of Helsinki on ethical testing of human subjects, and all patients gave informed, written consent prior to participating in the experiments.
Procedure
Contrast sensitivity was measured for luminance, red±green and blue±yellow cardinal stimuli immediately before¯uorescein angiography (following dilation) and after angiography following a sucient rest break (20 min). The three cardinal stimuli were selected so that each stimulus isolated one of the three postreceptoral colour mechanisms (Sankeralli and Mullen, 1997) . Angiography was performed routinely by the clinical sta using a KOWA RCXV fundus camera using blue excitor and barrier ®lters, and consisted of exposure to 20 light¯ashes to each eye under test.
The contrast sensitivity measurements were performed psychophysically using stimuli generated by a Barco CCID 7651 RGB monitor driven by a Dell 333D computer (for monitor speci®cations and calibration details see Sankeralli and Mullen, 1997) . The patient viewed the monitor at 1.5 m, and responded using a standard mouse. Patients who could not perform the task easily were excluded. The stimuli were 1 cycle per degree horizontal sinusoidal gratings (approx. 48 Â 48), which could be readily seen by the patient. The gratings were presented against a white background at 55 cd m À2 . A 4' dark ®xation spot was constantly presented to facilitate the patients' task. In each presentation, the grating appeared randomly in one of two 500 ms intervals each signalled by a tone. The patient indicated with a mouse-button press which interval contained the grating, and audio feedback was provided. Three colour stimuli were selected such that each uniquely activated the red±green, blue±yellow and luminance postreceptoral mechanisms. The stimuli were computed using a space based on estimates of the inputs to these mechanisms of the long-wavelength (L), medium-wavelength (M) and short-wavelength (S) cone responses (Sankeralli and Mullen, 1997) . The luminance stimulus was chosen to modulate all three cone-responses to an equal proportion (it therefore appeared achromatic), and the red± green and blue±yellow stimuli were selected based on previous estimates of cone inputs to the luminance, red±green and blue±yellow neural mechanisms (Sankeralli and Mullen, 1996) . Determinations of the red±green and blue±yellow cardinal colour stimuli were made for each patient individually using a minimum motion technique (Cavanagh et al., 1984) . In this simple procedure, a¯ickering (2 Hz) red±green or blue±yellow grating was titrated against a low, variable-contrast luminance grating until the point of minimum apparent¯icker was selected by the patient. This precise measurement of the isoluminant point is based on the phenomenon that¯icker is best perceived by the luminance mechanism. The isoluminant point directly yields the red±green and blue±yellow cardinal stimuli, since, at the point of minimum motion, the stimulus contains no luminance component, and is therefore detected solely on the basis of its chromatic contrast.
Contrast sensitivity was measured using a staircase procedure to determine contrast threshold (Sankeralli and Mullen, 1997) . One cardinal stimulus (red±green, blue±yellow or luminance) was presented in a single run lasting between 2 and 5 min. Each run began with a presentation of a clearly visible stimulus, and each successive presentation was adjusted in contrast according to the patient's previous response: a contrast increase of 0.1 log unit followed an incorrect response, an increase of 0.05 log unit followed two consecutive correct responses. Each run produced one measurement that represented the contrast level at which the grating was correctly detected 81.6% of the time. Three measurements were made for each patient for each of the three cardinal colour stimuli. Each measurement session (before or after angiography) therefore lasted 30±45 min. Table 2 shows the de®cit in contrast sensitivity for each of the three cardinal colour stimuli for each of the nine patients. We noted that the contrast sensitivities in general were all more than three times (0.5 log unit) lower than those of young, normal subjects (Sankeralli and Mullen, 1996) . This result is consistent with the established deterioration of visual sensitivity with aging (Young, 1994; Werner et al., 1990) and with ARMD (Haegerstrom-Portnoy, 1988; Applegate et al., 1987) . The average de®cits for luminance, red± green and blue±yellow contrast sensitivity are represented graphically in Figure 1 . The de®cit is com- Deficit is the difference between contrast sensitivity before and after fluorescein angiography. A positive deficit signifies deteriorated performance following angiography. The error measure for each patient represents the standard error of the three measurements for stimulus, while that of the average deficit is the standard error of the patient population (n = 9).
Results
b Denotes pseudophakic patient. Figure 1 . Average contrast sensitivity deficits following fluorescein angiography. The bar chart shows the mean deficit across patients for luminance, red±green and blue±yellow contrast sensitivity. The standard error of these deficits across patients (n = 9) was approximately 0.05 (Table 2) . Two-way ANOVA and Walsh tests reveal that the blue±yel-low deficit was statistically significant (a = 0.05).
puted as the dierence in log units between contrast sensitivity before and after¯uorescein angiography: a positive de®cit implies a lower contrast sensitivity following angiography. The mean de®cits across patients were found to be 0.04 log units (9%) for luminance, 0.02 log units (5%) for red±green, and 0.08 log units (17%) for blue±yellow. Thus, on average, the blue±yel-low de®cits were found to be higher than for luminance and red±green. More importantly from a clinical viewpoint, four patients out of the nine exhibited blue±yellow de®cits that were statistically signi®cant (two standard errors or greater). This compares with one patient showing luminance de®cits and none showing red±green de®cits. As a population, the de®cits in blue±yellow contrast sensitivity were found to be statistically signi®cant, as obtained from a two-way repeated-measures ANOVA test (a=0.05). On the other hand, the de®cits in red± green and luminance contrast sensitivity were not signi®cant (power < 0.15). These results were con®rmed by the results of a Walsh test (a=0.05) that relaxes the normality assumption on the data (Siegel, 1956) . To test whether the blue±yellow de®cits re¯ect an overall deterioration in performance for each patient after angiography (e.g., due to fatigue), we correlated these de®cits with those for luminance. We obtained a correlation coecient of 0.27, well below the critical value of 0.60 at the 5% signi®cance level. We therefore conclude that the blue±yellow de®cit arises from a cause that is independent of overall patient performance.
Discussion
We observe that blue±yellow contrast sensitivity exhibits a signi®cant deterioration following¯uorescein angiography. This is a new ®nding, and con¯icts with a recent study showing an absence of such de®cits (Friedman et al., 1994) . This discrepancy has several possible causes. Friedman et al. studied patients with assorted visual ailments including only three with ARMD. Our study may therefore reveal an eect speci®c to ARMD patients, consistent with hypothesised links between ARMD and light damage. Secondly, Friedman et al. used less sensitive techniques for evaluating red±green and blue±yellow de®cits (D-15 colour test and two-color increment thresholds). As these tests were designed to investigate much larger colour de®cits (as arise for example from congenital colour blindness), it is conceivable that our technique reveals de®cits that these other techniques do not. A third important consideration is that Friedman et al. tested for de®cits at much longer (48 h) after angiography than ours. It is entirely conceivable that the visual losses observed in our study are only temporary. However, we do not have the ethical means of testing our patients over a prolonged period to con®rm this hypothesis.
At the same time, the short onset of our observed blue±yellow de®cits has important consequences. Speci®cally, these visual de®cits occur well before the time of constant exposure (48 h) required to in¯ict ophthalmoscopically observable damage (Ham et al., 1980) . This occurrence of visual de®cits is also consistent with occasional subjective reports to one of the authors (JCC) of prolonged visual impairment following angiography. Our ®ndings indicate that visual de®-cits may occur earlier, and at lower levels of light exposure, than observable tissue damage. At the same time, our observed eects cannot be linked to¯eeting visual de®cits, such as dazzle recovery and transient tritanopia, which disappear well before the time of our testing after angiography (Collins and Brown, 1989; Haegerstrom-Portnoy and Verdon, 1991; Wisowaty, 1983; Mollon and Polden, 1979) .
The speci®city of contrast de®cits to blue±yellow sensitivity indicates possible sites for the occurrence of these de®cits. The ®rst site is that of S cones, which only has inputs to the blue±yellow neural mechanism and not to luminance and red±green (see Sankeralli and Mullen, 1996) . This hypothesis is supported by earlier evidence of the susceptibility of S cones to phototoxic damage by short-wavelength visible light (Sperling et al., 1980) . Alternatively, phototoxic damage may arise in the blue±yellow neural mechanism that arises from combination of cone signals in the early stages of retinal processing. In addition, it is still an open question what the causes of the blue±yellow sensitivity de®cits are. The de®cits may be caused by exposure to bright¯ashes or by the presence of the¯u-orescent dye. One study in rabbits (Hochheimer et al., 1987) suggests that it is combination of these two eects that is responsible for visual dysfunction. Mechanisms for the interaction between the phototoxic eects of the bright short-wavelength¯ashes and the chemotoxic eects of the dye have been proposed (Hochheimer et al., 1987; Gottsch et al., 1990) .
There are still several questions that require a much larger patient sample to resolve. Firstly, it is still an open question whether our results are speci®c to ARMD patients, although a comparison with the results of Friedman et al. (1994) and the link between light damage and ARMD suggest that such speci®city is plausible. Secondly, it would be useful to track the progress of these visual de®cits with that of ARMD. In our study, for instance, we observed that the patient with the most severe case of ARMD (6) also exhibited the largest de®cit. Finally, a large volume of testing is required to ascertain whether our observed de®cits in blue±yellow sensitivity disappear after a suf®cient recovery time. Nonetheless, our results identify 140
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